Tranylcypromine/trifluoperazine
Combination drug / From Wikipedia, the free encyclopedia
Tranylcypromine/trifluoperazine (brand names Parstelin, Parmodalin, Jatrosom N, Stelapar) is a combination formulation of the monoamine oxidase inhibitor antidepressant drug tranylcypromine and the typical antipsychotic drug trifluoperazine that has been used in the treatment of major depressive disorder.[1][2][3] It contains 10 mg tranylcypromine and 1 mg trifluoperazine.[3][4] The drug has been in clinical use since at least 1961.[3]
Quick Facts Combination of, Trifluoperazine ...
Combination of | |
---|---|
Tranylcypromine | Monoamine oxidase inhibitor |
Trifluoperazine | Typical antipsychotic |
Clinical data | |
Trade names | Parstelin, Parmodalin, Jatrosom N, Stelapar |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
Close
It may come to assume a certain place in the treatment of borderline personality disorder.[5]